Combination therapy for advanced tumors
Treatments studied
Part of Cancer clinical trials.
This study tests a new combination therapy for people with advanced tumors that have not responded to other treatments. The goal is to see if the combination can shrink tumors and improve well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are able to do your daily activities with little or no help (ECOG 0 or 1).
- You have been diagnosed with advanced cancer (solid tumors) that has spread or cannot be removed by surgery.
- You have at least one tumor that can be measured on a scan.
- You have not taken any cancer treatment in the last 4 weeks before starting the study.
- You have not had treatment with a medicine called a '4-1BB agonist' or '4-1BB fusion protein' before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of drugs for people with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to see if the combination can shrink tumors and improve outcomes.
This trial tests a combination of two new treatments (QLP2117 and QL2107) for people with advanced solid tumors that have not responded to standard therapy. The goal is to see if the combination can shrink tumors or slow cancer growth.
This trial tests a new drug called QLC5508, given in combination with other treatments, for people with advanced solid tumors that have stopped responding to standard therapy or who haven't had treatment yet. The goal is to see if the combination can shrink tumors or slow their growth.
This trial tests a new combination of drugs (FC084CSA plus tislelizumab) for people with advanced solid tumors, especially lung cancer that has gotten worse after prior immunotherapy and chemotherapy. It may be an option if you've tried standard treatments and they no longer work.
This study tests a new combination of drugs and targeted radiation for people with advanced colorectal cancer that has spread to a few spots. It aims to see if this approach works better than the current standard treatment after other therapies have failed.
This trial tests a combination of three drugs—axatilimab, retifanlimab, and paclitaxel—for people with advanced solid tumors that have spread. It aims to see if this combination can shrink tumors or slow their growth, and it is for people who have already tried taxane chemotherapy.
Hear when a new Advanced Malignant Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.